US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.77

-0.1591-0.57%

Volume:139

Turnover:4K

Market Cap:1.39M

PE:- -

High:27.95

Open:27.95

Low:27.77

Close:27.93

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:0.69

T/O Rate:0.28%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

US FDA - Approves Juvmo (Tavapadon) for Parkinson’s Disease in Adults on Sept 25, 2026

THOMSON REUTERS

ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO

Align Technology Inc. Stock Underperforms Thursday When Compared to Competitors

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says

MT Newswires Live

Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults

Epkinly® Receives Health Canada Approval for Adults with Follicular Lymphoma

THOMSON REUTERS

Italy's Giglio.com H1 Revenue Falls, Net Loss Widens

Align Technology Inc. Stock Underperforms Wednesday When Compared to Competitors

Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15

Sector Update: Consumer Stocks Decline Wednesday Afternoon

MT Newswires Live

Estee Lauder enters five-year commitment with Breast Cancer Research Foundation

Oruka Falls After Reporting Mid-Stage Data for Psoriasis Drug

Deals of the Day-Mergers and Acquisitions

Kimberly-Clark Offers Remedies in Bid for EU Approval of Kenvue Deal

Cboe data suggests bullish flow in Hims and Hers Health with shares up 3.56%

AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)

AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/GLAM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":27.766,"timestamp":1790798400000,"preClose":27.9251,"halted":0,"volume":139,"delay":0,"changeRate":-0.005697383357624583,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.1591,"latestTime":"10-01 07:23:25 EDT","open":27.95,"high":27.95,"low":27.766,"amount":3887,"amplitude":0.006589,"askPrice":44.14,"askSize":100,"bidPrice":11.17,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790861400000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":27.766,"nav":27.92,"aum":1396000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.95,"preClose":27.766,"latestTime":"16:15 EDT","volume":8,"amount":222.128,"timestamp":1790799300221,"change":0.184,"changeRate":0.006627,"amplitude":0},"volumeRatio":0.6860811847269641,"impliedVol":0.5992,"impliedVolPercentile":0.7204},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6860811847269641,"shares":50000,"dividePrice":0,"high":27.95,"amplitude":0.006589,"preClose":27.9251,"low":27.766,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":27.766,"eps":0,"divideRate":0,"volume":139,"delay":0,"ttmEps":0,"open":27.95,"prevYearClose":25.82,"prevWeekClose":28.1493,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":28.1821,"twentyDayClose":28.6876,"sixtyDayClose":28.3416},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670099422","title":"US FDA - Approves Juvmo (Tavapadon) for Parkinson’s Disease in Adults on Sept 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2670099422","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670099422?lang=en_us&edition=fundamental","pubTime":"2026-09-26 05:53","pubTimestamp":1790373204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45H13J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","ABBV","GLAM","LU0158827948.USD","LU1989772840.SGD","IXJ","LU2347655156.SGD","TRUH","LU2089984988.USD","LU0320765646.SGD","LU1732800096.USD","LU0820561909.HKD","LU0868494617.USD","LU0198837287.USD","LU0942090050.USD","SG9999015945.SGD","LU1718418525.SGD","LU1244550577.SGD","VHT","XLV","LU0861579265.USD","MEDX","RXL","LU0708994859.HKD","IE0000B7K699.USD","LU0661504455.SGD","BK4588","LU1061106388.HKD","LU2023251221.USD","FHLC","LU0069063385.USD","LU1923622614.USD","IE000F7OJYX1.SGD","LU2237443895.HKD","LU1934455863.HKD","IE00BVYPNV92.GBP","IYH","PJP","FTXH","LU1934455194.USD","IE00BDGV0183.EUR","AGNG","IE00BVYPNW00.USD","LU0511384066.AUD","LU1839511570.USD","LU1496350171.SGD","LU0545039389.USD","LU0234572021.USD","PPH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442662","title":"ADARx Pharmaceuticals Shares Soar in NASDAQ Debut After Upsized IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442662","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442662?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:21","pubTimestamp":1790353284,"startTime":"0","endTime":"0","summary":"UPDATE 2-ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPOSept 25 (Reuters)-Shares of ADARx PharmaceuticalsADRX.Orose 30% above their initial public offering price on Friday after th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H0ML:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU0058720904.USD","LU2129689605.HKD","AGNG","IE00BDGV0183.EUR","LU0320765646.SGD","LU1670627923.USD","IE0009355771.USD","ETRA","LU1548497426.USD","FHLC","FTXH","XLV","ADRX","LU0965509283.SGD","LU0868494617.USD","LU1983299246.USD","TRUH","BK4585","LU0158827948.USD","ABBV","LU0942090050.USD","LU0912757837.SGD","IE00BSNM7G36.USD","LU1037948897.HKD","IE0000B7K699.USD","PJP","JDOC","IE00B4R5TH58.HKD","LU1061106388.HKD","IE00B42XCP33.USD","MEDX","LU2237443465.HKD","IE00B19Z3581.USD","IE00BGHQF631.EUR","RXL","LU0098860793.USD","LU0545039389.USD","IXJ","LU0823416689.USD","LU1003077747.HKD","LU1839511570.USD","PPH","LU2237443382.USD","IYH","VHT","LU0511384066.AUD","LU1989771016.USD","LU2023251221.USD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670841310","title":"Align Technology Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670841310","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670841310?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:16","pubTimestamp":1790284560,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  slipped 1.72% to $145.63 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Align Technology Inc. closed 27.35% short of its 52-week high of $200.44, which the company reached on April 21st.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Zimmer Biomet Holdings Inc.  fell 1.31% to $89.69 and Dentsply Sirona Inc.  fell 2.56% to $9.53.Trading volume  remained 137,121 below its 50-day average volume of 916,893.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU1974910355.USD","LU2023250504.SGD","LU1201861249.SGD","LU1917777945.USD","ZBH","LU0477156953.USD","LU0006061336.USD","LU0310800379.SGD","LU1267930490.SGD","LU1267930573.SGD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0130517989.USD","LU2106854487.HKD","LU0211327993.USD","LU0648001328.SGD","LU0889566641.SGD","LU2023250843.SGD","BK4566","LU0310799852.SGD","ALGN","GLAM","LU0211328371.USD","IE00B19Z3B42.SGD","LU0128525929.USD","LU0792757196.USD","BK4585","LU0708994859.HKD","LU0130102774.USD","LU0029864427.USD","LU1267930813.SGD","XRAY","BK4198","BK4534","BK4588","BK4082","LU0980610538.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413314","title":"Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413314","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413314?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:55","pubTimestamp":1790283300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  slipped 3.50% to $95.37 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Estee Lauder Cos. Cl A closed 21.59% below its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Procter & Gamble Co.  fell 1.16% to $145.68, and Coty Inc. Cl A  fell 0.38% to $2.63.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","XLP","FSTA","JNJ","UGE","LU2347655156.SGD","BMED","LU1043141396.HKD","LU1066051811.HKD","GLAM","LU0942090050.USD","SG9999014542.SGD","XLV","MEDX","VHT","IYH","FTXH","BK4585","GDOC","IE000MB6IJN5.SGD","IHE","PG","LU2264538146.SGD","LU2552382132.HKD","LU0057025933.USD","LU0553294199.USD","LU1585245621.USD","EL","BK4533","LU1674673428.USD","IE00BSNM7G36.USD","LU1914381329.SGD","PJP","LU2592432038.USD","TRUH","JDOC","IE00BFTCPJ56.SGD","IE000BZT7R73.USD","TRUO","LU2750360641.GBP","FHLC","SG9999014575.USD","LU0795875169.SGD","LU0114720955.EUR","IE0034235303.USD","LU0738911758.USD","IXJ","IE00BBT3K403.USD","COTY","IE00B1XK9C88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492787","title":"Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492787","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492787?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:02","pubTimestamp":1790269368,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics'  lead program of long-acting IL-23 in moderate-to-severe psoriasis maintains a \"competitive profile\" after positive week 28 clinical data, UBS said in a Wednesday note.Oruka's ORKA-001 increased its Psoriasis Area and Severity Index-100 score, which represents the complete resolution of psoriasis, to 71% from 64% in week 16. This compares favorably with rival product, AbbVie's  Skyrizi, which rose to 53% from 43% in the same period, UBS analysts said.The safety data was also consistent with prior data, as treatment-emergent adverse events were 36% in the period of week 16 to 28, compared with 51% during week zero to 16. There were also no injection site reactions and no impact of anti-drug antibodies on safety, efficacy and pharmacokinetics, the analysts noted.The analysts said they are confident in the company's multiple additional readouts later in the year to be positive, \"given the de-risking provided by previous datasets\".UBS' rating on the company's stock is b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GLAM","SG9999015986.USD","LU0211327993.USD","XLV","BK4588","SG9999001440.SGD","ORKA","RXL","LU0256863811.USD","LU1093756168.USD","LU0114720955.EUR","LU2237443549.SGD","IE00BLSP4239.USD","MEDX","PJP","LU0256863902.USD","IE00B19Z3B42.SGD","LU2129689514.USD","LU0289961442.SGD","LU0198837287.USD","LU0795875169.SGD","FTXH","LU0029864427.USD","LU1003077747.HKD","IE000WAW04H5.SGD","FHLC","AGNG","BK4007","IE000F7OJYX1.SGD","LENZ","JDOC","LU0985320562.USD","VHT","LU0320765646.SGD","IE00BSNM7G36.USD","IE00BN8TJ469.HKD","PPH","IE00BVYPNW00.USD","LU1934455863.HKD","LU2133065610.SGD","TRUH","LU0395794307.EUR","BK4550","BK4585","IXJ","IYH","LU0124676726.USD","LU0511384066.AUD","ABBV","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669629644","title":"Health Canada Approves AbbVie’s Epkinly Combo for Relapsed or Refractory Follicular Lymphoma in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2669629644","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669629644?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:03","pubTimestamp":1790247822,"startTime":"0","endTime":"0","summary":"Health Canada approves AbbVie’s EPKINLY combo for relapsed or refractory follicular lymphoma in adultsHealth Canada cleared AbbVie’s EPKINLY (epcoritamab) with lenalidomide, rituximab for relapsed or ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLbtn36S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","AGNG","LU0965509101.SGD","LU2237443895.HKD","LU0708994859.HKD","LU1496350171.SGD","LU0114720955.EUR","PPH","GLAM","LU2347655073.USD","XLV","LU0310799852.SGD","SG9999003800.SGD","SG9999011175.SGD","LU2237443465.HKD","VHT","FTXH","LU0289961442.SGD","LU0553294199.USD","LU0820561909.HKD","TRUH","IYH","LU1291159041.SGD","MEDX","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","LU0069063385.USD","ABBV","LU1670627923.USD","IE00BLSP4239.USD","LU0417517546.SGD","SG9999015978.USD","FHLC","IXJ","LU2357305700.SGD","IE0002270589.USD","IE00BGHQF631.EUR","PJP","IE00BN8TJ469.HKD","IE00BJJMRZ35.SGD","LU1037948897.HKD","RXL","IE00B19Z3581.USD","JDOC","BK4533","LU0661504455.SGD","LU0859254822.USD","LU0310800379.SGD","LU1934455863.HKD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669625764","title":"Epkinly® Receives Health Canada Approval for Adults with Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2669625764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669625764?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:01","pubTimestamp":1790247660,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA7YJCP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABBV","LU1934455277.USD","LU2237443978.SGD","LU0122379950.USD","LU2023251221.USD","LU1244550494.USD","FHLC","LU0823416689.USD","BK4566","LU0114720955.EUR","LU0124676726.USD","LU0057025933.USD","LU1989771016.USD","XLV","MEDX","LU1267930573.SGD","IE00BGHQF631.EUR","LU2129689431.USD","IYH","IE00B19Z3581.USD","AGNG","VHT","LU0985320562.USD","JDOC","LU0456855351.SGD","RXL","IE00BLSP4239.USD","LU0234572021.USD","TRUH","LU2125909247.SGD","IE0002141913.USD","BK4139","LU1236620750.USD","LU0708994859.HKD","GLAM","IE00B4R5TH58.HKD","IXJ","LU0289739343.SGD","IE00BJT1NW94.SGD","PPH","LU1430594728.SGD","BK4588","LU1983299246.USD","LU0943347566.SGD","PJP","FTXH","IE000BZT7R73.USD","LU0661504455.SGD","LU2087621335.USD","LU0472753341.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462389","title":"Italy's Giglio.com H1 Revenue Falls, Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462389","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462389?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:59","pubTimestamp":1790247555,"startTime":"0","endTime":"0","summary":"Italy's Giglio.com H1 revenue falls, net loss widensOverviewItaly online luxury retailer's half-year revenue declined 1% yr/yr, reversing prior declinesNet loss widened to EUR 1.9 mln from EUR 1.3 mln","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G0BZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG0V08.USD","LU0310800379.SGD","LU1430594728.SGD","LU1585245621.USD","BK4558","NKE","BK4533","BK4018","BK4504","BK4534","LU1267930813.SGD","BK4561","SG9999001440.SGD","LU0128525689.USD","BK4146","LU1303367103.USD","LU2098885051.SGD","RSPS","BK4585","LU0029864427.USD","BK4581","LU2463526074.USD","LU0052756011.USD","STYL","BK4183","LU0786609619.USD","LU0310800965.SGD","IE00B3T34201.USD","LU0708994859.HKD","LU0128525929.USD","IE00BFXG1179.USD","KVUE","BK4567","IE00BYQQ9H92.USD","BK4588","LU1267930573.SGD","KMB","LU1571399168.USD","LU0823411888.USD","BK4566","LU0792757196.USD","GLAM","LU0889566641.SGD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669439280","title":"Align Technology Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669439280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669439280?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:15","pubTimestamp":1790198100,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  shed 3.34% to $148.17 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.75% to 7,706.03 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.Align Technology Inc. closed 26.08% below its 52-week high of $200.44, which the company achieved on April 21st.The stock underperformed when compared to some of its competitors Wednesday, as Zimmer Biomet Holdings Inc.  fell 3.30% to $90.88 and Dentsply Sirona Inc.  fell 1.71% to $9.78.Trading volume  eclipsed its 50-day average volume of 898,707.Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","IE00B19Z3581.USD","LU0130517989.USD","IE0002270589.USD","LU1201861249.SGD","LU0130102774.USD","LU0889566641.SGD","BK4534","LU1267930490.SGD","LU0029864427.USD","LU0792757196.USD","ALGN","BK4082","LU1917777945.USD","LU1974910355.USD","LU0211327993.USD","BK4588","BK4504","IE00B7SZLL34.SGD","BK4198","ZBH","GLAM","BK4585","LU2106854487.HKD","XRAY","LU0128525929.USD","LU0310799852.SGD","LU0708994859.HKD","LU0980610538.SGD","LU0006061336.USD","LU0310800379.SGD","LU1267930813.SGD","LU1267930573.SGD","LU2023250843.SGD","IE00B19Z3B42.SGD","BK4566","LU2023250504.SGD","LU0477156953.USD","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436685","title":"Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436685","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436685?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:17","pubTimestamp":1790194672,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe sells 29,277 common shares for $876,846.15Hims & Hers Health CFO Oluyemi Okupe sold 29,277 Class A shares on Sept. 22 at USD 29.95.Okupe exercised options for 14,000 shar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL8NjRcH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMC","GLAM","HIMZ","HIYY","BK4196","HIMS","HIMY","HMYY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669543814","title":"Sector Update: Consumer Stocks Decline Wednesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2669543814","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669543814?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:35","pubTimestamp":1790184911,"startTime":"0","endTime":"0","summary":"Consumer stocks were lower Wednesday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF  decreasing 0.4% and the State Street Consumer Discretionary Select Sector SPDR ETF  falling 1.6%.In corporate news, McDonald's  said Wednesday it will provide $8.5 billion in support to franchisees through 2036 to accelerate restaurant modernization, technology deployment, and operational improvements. Its shares fell past 5%.KB Home  shares lost 1% after the homebuilder lowered its full-year housing gross profit margin estimates amid weaker market conditions and affordability pressures.Kimberly-Clark  has submitted remedies to address EU antitrust concerns regarding its $40 billion purchase of Kenvue , Reuters reported. Kimberly-Clark shares were down 1%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1732799900.SGD","KMB","LU1732800096.USD","LU1894683264.USD","IE00BJJMRY28.SGD","LU0868494708.USD","LU1074936037.SGD","BK4534","LU1894683348.USD","LU1244550221.USD","IE0034235188.USD","BK4088","XLPU","LU0795875169.SGD","LU2347655073.USD","IE00BFSS7M15.SGD","LU0417517546.SGD","BK4018","IE00B7KXQ091.USD","LU1244550494.USD","LU1267930573.SGD","LU1244550577.SGD","LU2463526074.USD","IE00BJTD4N35.SGD","XHB","KVUE","BK4135","KBH","LU0726765562.USD","IE00B3QW5Z07.USD","RSPS","LU2347655156.SGD","MCD","GLAM","XLY","LU1430594728.SGD","XLPD","LU2279689827.SGD","BK4610","LU1035773651.USD","STT","IE00BFXG1179.USD","LU0029864427.USD","LU1718418525.SGD","BK4566","LU0942090050.USD","XLP","IE00BFSS8Q28.SGD","IE00BJTD4V19.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486136","title":"Estee Lauder enters five-year commitment with Breast Cancer Research Foundation","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486136?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:50","pubTimestamp":1790167857,"startTime":"0","endTime":"0","summary":"The Estee Lauder (EL) Companies announced a new five-year commitment to the Breast Cancer Research Foundation to establish the Global Research Init...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/estee-lauder-enters-five-year-commitment-with-breast-cancer-research-foundation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/estee-lauder-enters-five-year-commitment-with-breast-cancer-research-foundation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","BK4183","LU2404859667.USD","BK4558","LU2404859741.USD","LU1064131342.USD","LU2552382058.USD","LU1988902786.USD","BK4533","EL","BK4585","LU2552382215.SGD","BK4504","LU0690374961.EUR","BK4588","LU2552382132.HKD","BK4548","LU0690374615.EUR","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669486848","title":"Oruka Falls After Reporting Mid-Stage Data for Psoriasis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486848","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486848?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:47","pubTimestamp":1790167639,"startTime":"0","endTime":"0","summary":"BUZZ-Oruka falls after reporting mid-stage data for psoriasis drug** Shares of drug developer Oruka TherapeuticsORKA.Ofall 3.8% to $91 premarket** Co says its experimental drug ORKA-001 showed continu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4N45F0US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","FHLC","LU0320765992.SGD","XLV","PPH","IE00BFTCPJ56.SGD","LU0234570918.USD","IXJ","JDOC","AGNG","IE000MB6IJN5.SGD","LU0320765646.SGD","LU1057294990.SGD","FTXH","VHT","LU0965509283.SGD","LU1236620750.USD","BK4550","LU1839511570.USD","LU1551013425.SGD","LU1934455194.USD","LU1983299246.USD","LU0170899867.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU0868494708.USD","IE0002141913.USD","LU1934455863.HKD","BK4581","IYH","LU0545039389.USD","LU1093756325.SGD","LU0058720904.USD","LU2089984988.USD","LU0029864427.USD","LU0234572021.USD","RXL","ABBV","LU2237443465.HKD","IE00B3PB1722.GBP","GLAM","IE00BBT3K403.USD","MEDX","LU1061106388.HKD","ORKA","PJP","TRUH","LU1244550577.SGD","LU1670627923.USD","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669102798","title":"Deals of the Day-Mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669102798","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669102798?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:07","pubTimestamp":1790158039,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsSept 23 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Wednesday:** The billionaire family behind H&MHMb.STis q","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4N45F0N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4517","BK4588","WNDR","RSPS","BK4018","LU1267930813.SGD","IE00B3T34201.USD","LU0792757196.USD","BK4183","LU2463526074.USD","KMB","LU1670628061.USD","RCL","BK7034","BK4566","LU0889566641.SGD","LU0310800379.SGD","BK4585","LU1571399168.USD","BK4142","IAG.AU","LU1267930573.SGD","LU1366192091.USD","LU0708994859.HKD","LU1430594728.SGD","LU0128525929.USD","SG9999001440.SGD","BK4504","LU0266013472.USD","BK4567","IE00BFXG1179.USD","LU0029864427.USD","LU1585245621.USD","LU1670627923.USD","GLAM","KVUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104698","title":"Kimberly-Clark Offers Remedies in Bid for EU Approval of Kenvue Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104698","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669104698?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:32","pubTimestamp":1790155921,"startTime":"0","endTime":"0","summary":"Kimberly-Clark offers remedies in bid for EU approval of Kenvue dealBRUSSELS, Sept 23 (Reuters)-Kimberly-ClarkKMB.Ohas offered concessions to address EU antitrust concerns about its $40 billion bid fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL8N45A15Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU2129689605.HKD","LU1061106388.HKD","LU0122379950.USD","BK4550","LU2505996681.GBP","LU1732800096.USD","IE00BFXG1179.USD","LU1221951129.SGD","JDOC","IXJ","BK4568","SG9999001176.USD","MEDX","JNJ","LU2023250330.USD","RXL","IE0001KFT4U8.USD","LU0511384066.AUD","LU1674673691.USD","BMED","RSPS","LU2592432038.USD","LU0738911758.USD","LU1732799900.SGD","TRUH","IYH","XLV","KMB","PJP","IE0002141913.USD","IHE","FTXH","LU0795875169.SGD","LU1066051225.USD","FHLC","LU0689626769.HKD","LU0553294199.USD","VHT","KVUE","LU1196500208.SGD","LU1221951046.USD","GLAM","LU2487616109.SGD","LU2505996509.AUD","LU2236285917.USD","GDOC","LU0345769631.USD","LU2750360641.GBP","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669386126","title":"Cboe data suggests bullish flow in Hims and Hers Health with shares up 3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669386126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669386126?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:25","pubTimestamp":1790094312,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Hims and Hers Health (HIMS), with shares up $1.04, or 3.56%, near $30.39. Options volume running well above aver...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-3-56-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-3-56-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIYY","HIMZ","GLAM","HIMY","THNR","BK4196","HMYY","HEAL","HIMS","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669125714","title":"AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669125714","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669125714?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:23","pubTimestamp":1790094183,"startTime":"0","endTime":"0","summary":"AbbVie tells USTR Germany drug pricing reforms cut innovative medicine value by nearly 54%AbbVie testified in a USTR Section 301 probe into Germany, arguing drug pricing and reimbursement policies und","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDLZgjZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0057025933.USD","GLAM","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU1244550221.USD","LU2089284900.SGD","LU1244550494.USD","LU1162221912.USD","LU1267930573.SGD","LU0912757837.SGD","LU0122379950.USD","VHT","LU0868494617.USD","LU1989772840.SGD","FHLC","IE00BSNM7G36.USD","LU0726765562.USD","LU0965509283.SGD","LU2023251221.USD","LU0859254822.USD","PJP","BK4581","TRUH","FTXH","LU2129689431.USD","ABBV","LU0965509010.AUD","XLV","LU0882574055.USD","LU0689626769.HKD","LU0943347566.SGD","PPH","SG9999015945.SGD","MEDX","IE00B19Z3581.USD","LU2237443465.HKD","JDOC","LU2133065610.SGD","LU0985320562.USD","IYH","IXJ","LU1934455863.HKD","LU0310799852.SGD","LU2347655073.USD","IE000MB6IJN5.SGD","LU0820561818.USD","LU2357305700.SGD","RXL","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669914330","title":"AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669914330","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669914330?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:55","pubTimestamp":1790070911,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the European Commission has approved Rinvoq for the treatment of active polyarticular juvenile idiopathic arthritis in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-ec-approves-rinvoq-to-treat-polyarticular-juvenile-idiopathic-arthritis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-ec-approves-rinvoq-to-treat-polyarticular-juvenile-idiopathic-arthritis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B42XCP33.USD","LU1934455277.USD","MEDX","ABBV","LU1074936037.SGD","IE00BJT1NW94.SGD","LU1670628061.USD","FTXH","AGNG","PPH","IXJ","JDOC","SG9999015945.SGD","GLAM","LU0234570918.USD","LU0738911758.USD","TRUH","LU0203347892.USD","IE00BVYPNW00.USD","LU2089284900.SGD","IE0004445239.USD","VHT","LU0943347566.SGD","IYH","LU2357627491.SGD","LU2089984988.USD","LU1923622614.USD","LU0708994859.HKD","LU0289739343.SGD","FHLC","LU0432979614.USD","LU0456855351.SGD","LU1093756168.USD","PJP","LU1718418525.SGD","LU2129689514.USD","RXL","LU0198837287.USD","XLV","LU1732799900.SGD","LU0861579265.USD","SG9999015986.USD","LU0256863902.USD","LU1732800096.USD","IE0009355771.USD","EPV","IE00BLSP4239.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU0395794307.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669119912","title":"AbbVie Announces European Commission Approval of Rinvoq (Upadacitinib)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669119912","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669119912?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:41","pubTimestamp":1790059265,"startTime":"0","endTime":"0","summary":"BRIEF-AbbVie Announces European Commission Approval Of RINVOQ (Upadacitinib)Sept 22 (Reuters)-AbbVie Inc.ABBV.N:ABBVIE ANNOUNCES EUROPEAN COMMISSION APPROVAL OF RINVOQ (UPADACITINIB) FOR THE TREATMENT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUA9MJJCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU0211328371.USD","BK4588","LU1093756168.USD","MEDX","LU0069063385.USD","LU0203347892.USD","XLV","IE00BLSP4452.SGD","IE00BGHQF631.EUR","IE000MB6IJN5.SGD","LU0943347566.SGD","LU0795875086.SGD","LU2112291526.USD","TRUH","LU1934455194.USD","IE0002270589.USD","LU1236620834.HKD","IE00BBT3K403.USD","SG9999015986.USD","LU0310800379.SGD","VHT","LU0689626769.HKD","JDOC","FTXH","IE00BN8TJ469.HKD","IYH","LU0114720955.EUR","LU0256863902.USD","AGNG","FHLC","PJP","RXL","LU1989772840.SGD","LU0985320562.USD","LU2129689514.USD","LU0057025933.USD","IE00B2B36J28.USD","LU1720051108.HKD","LU2357627491.SGD","IXJ","IE00B42XCP33.USD","LU1989771016.USD","LU0029864427.USD","PPH","LU2023251221.USD","ABBV","LU1548497426.USD","GLAM","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669116311","title":"AbbVie Says EU Approves Rinvoq for Children with Polyarticular Juvenile Idiopathic Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669116311","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669116311?lang=en_us&edition=fundamental","pubTime":"2026-09-22 14:01","pubTimestamp":1790056875,"startTime":"0","endTime":"0","summary":"AbbVie says EU approves Rinvoq for children with polyarticular juvenile idiopathic arthritisEuropean Commission cleared AbbVie’s Rinvoq for active polyarticular juvenile idiopathic arthritis in patien","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1SztCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000SO60NU8.SGD","BK4533","LU0823416689.USD","LU0868494617.USD","LU1732799900.SGD","PPH","LU0432979614.USD","LU0256863811.USD","IE00BSNM7G36.USD","LU0472753341.HKD","TRUH","LU1934455277.USD","LU1720051108.HKD","BK4550","IE00BVYPNW00.USD","LU0965509283.SGD","LU2347655156.SGD","LU2357627491.SGD","MEDX","LU2112291526.USD","LU0820561909.HKD","JDOC","IE00BJT1NW94.SGD","RXL","FHLC","IE00BVYPNV92.GBP","IYH","LU2125909247.SGD","LU1983299246.USD","VHT","FTXH","AGNG","LU0882574055.USD","PJP","LU1989771016.USD","GLAM","ABBV","XLV","LU1236620750.USD","LU0057025933.USD","LU0058720904.USD","SG9999015986.USD","LU2125909593.SGD","BK4588","LU1989772840.SGD","LU0965508806.USD","LU0985320562.USD","LU0320765646.SGD","LU0912757837.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}